http://web.archive.org/web/20140829201149id_/http://www.dailymail.co.uk/health/article-2732378/Watchdog-examine-safety-clot-busting-stroke-drug-experts-increase-risk-bleeding-brain.html

by @entity1 reporter the medicines watchdog is to review the safety of a clot - busting drug used to treat strokes			1
the @entity6 ( @entity6 ) is re-examing evidence on the benefits of alteplase after experts said previous assessments may have been flawed			2
patients are given the drug to disperse clots in a treatment known as thrombolysis			0
it leads to an increased risk of bleeding in the brain , but evidence suggested the danger was outweighed by the benefits of an improved recovery			2
the @entity6 has been asked to have another look at the drug after claims previous assessments on the clot - busting drug may be flawed , picture posed by models however , dr @entity29 , a stroke specialist , raised concerns in a letter published in @entity33			1
he told the @entity34 : ‘ my concerns using alteplase for stroke have always been that the risks of this drug are quite considerable , particularly with bleeding into the brain			0
the question is , do the benefits justify that risk ? and i am not myself convinced that they do			0
’ the @entity6 recently reaffirmed that the benefits outweighed the risk but also said it was setting up an expert working group ‘ to ensure all relevant sources of evidence have been taken into consideration ’			1
it is expected to report back next year			0
@entity52 manufacturer @entity51 said it stood by the safety of alteplase			0
dr @entity29 asked in @entity33 whether the risks posed by alteplase outweighed any benefits			1

fears have been raised over the safety of clot - busting drug alteplase
expert dr @entity29 fears it may increase the risk of a brain bleed
@entity6 has been asked to re-examine evidence concerning drug *'s* the safety

@entity33:The Lancet
@entity6:MHRA
@entity29:Roger Shinton
@entity1:Daily Mail
@entity52:German
@entity51:Boehringer Ingelheim
@entity34:BBC